This inventor holds 3 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yang Gao - Innovator in Cancer Treatment
Introduction
Yang Gao is a prominent inventor based in Boston, MA, known for his contributions to the field of cancer treatment. He has developed innovative compounds that have the potential to significantly impact the medical community. His work focuses on creating effective therapies for various diseases, including cancers and inflammatory conditions.
Latest Patents
Yang Gao holds a patent for "Pyrazolopyridine inhibitors of c-Jun-n-Terminal kinases and uses thereof." This patent includes compounds of Formula (I), along with pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopologues, prodrugs, and compositions thereof. The patent outlines methods and kits that utilize these inventive compounds or compositions for treating and preventing diseases such as proliferative diseases, inflammatory diseases, and vascular diseases. Specifically, it provides methods for inhibiting JNK (e.g., JNK1, JNK2, or JNK3) in a subject.
Career Highlights
Yang Gao is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research and development efforts. His work is instrumental in the ongoing fight against cancer and other serious health conditions. With a focus on innovative solutions, he aims to improve patient outcomes through his discoveries.
Collaborations
Yang Gao collaborates with various professionals in his field, including his coworker Tinghu Zhang. These partnerships enhance the research and development process, allowing for a more comprehensive approach to tackling complex medical challenges.
Conclusion
In summary, Yang Gao is a dedicated inventor whose work in developing pyrazolopyridine inhibitors showcases his commitment to advancing cancer treatment. His innovative approach and collaboration with other experts in the field position him as a key player in the ongoing battle against serious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
